Page last updated: 2024-10-21

phenytoin and Hamartoma Syndrome, Multiple

phenytoin has been researched along with Hamartoma Syndrome, Multiple in 1 studies

Hamartoma Syndrome, Multiple: A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with mutations in the gene for PTEN PHOSPHATASE.

Research Excerpts

ExcerptRelevanceReference
"In this study brain tumors developing with tuberous sclerosis were biologically benign; total transcortical tumor removal permanently relieved the attending cerebral hypertension and achieved prolonged survival without notable functional impairment."2.35Brain tumors in hereditary multiple system hamartomatosis (tuberous sclerosis). ( Cooper, JR, 1971)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, JR1

Reviews

1 review available for phenytoin and Hamartoma Syndrome, Multiple

ArticleYear
Brain tumors in hereditary multiple system hamartomatosis (tuberous sclerosis).
    Journal of neurosurgery, 1971, Volume: 34, Issue:2 Pt 1

    Topics: Anticonvulsants; Astrocytoma; Brain Neoplasms; Cerebral Ventricles; Child; Diagnosis, Differential;

1971